Table 5.
Relationship between primary site, pathologic subtype and metastasis
| Site | |||||||
|
|
|||||||
| Metastasis | Total n (%) | Head/neck n (%) | Genit n (%) | Extremities n (%) | Getrop n (%) | Others n (%) | P value |
|
| |||||||
| -ve | 101 (62.7) | 38 (76.0) | 42 (60.0) | 13 (72.2) | 4 (40.0) | 4 (30.8) | 0.014 |
| +ve | 60 (37.3) | 12 (24.0) | 28 (40.0) | 5 (27.8) | 6 (60.0) | 9 (69.2) | |
| Total | 161 (100) | 50 (31.1) | 70 (43.5) | 18 (11.2) | 10 (6.2) | 13 (8.1) | |
|
| |||||||
| Pathologic subtype | |||||||
|
|
|||||||
| Metastasis | Total n (%) | Embryoyonal + Botryoid + Spindle cell + Others n (%) | Alveolar n (%) | P value | |||
|
| |||||||
| -ve | 106 (65.8) | 95 (66.9) | 6 (31.6.1) | 0.004 | |||
| +ve | 55 (34.2) | 44 (33.1) | 13 (68.4) | ||||
Retro: retroperitoneum; Genit: genitourinary.